h-header

news

News dal mondo

20

Set

EMA: I farmaci biosimilari sono intercambiabili con il loro medicinale di riferimento

EMA and the Heads of Medicines Agencies (HMA) have issued a joint statement confirming that biosimilar medicines approved in the European Union (EU) are interchangeable with their reference medicine or with an equivalent biosimilar.

While interchangeable use of biosimilars is already practiced in many Member States, this joint position harmonises the EU approach. It brings more clarity for healthcare professionals and thus helps more patients to have access to biological medicines across the EU....[EMA]

24

Nov

Applicazioni biotecnologiche. Gli aspetti normativi e i progetti INAIL

Le biotecnologie rappresentano un insieme di tecnologie che trovano applicazione in diversi settori industriali...

23

Nov

ICH touts adoption of continuous manufacturing, safety reporting guidelines

The International Council for Harmonisation (ICH) announced that “excellent progress” has...

23

Nov

Frequent Deficiencies In GMP Inspections

If a film were made on GMP inspections, it could be titled GMP Inspections Feel like Groundhog Day....

slider-banner

h-footer